Crossmark Global Holdings’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,042
| Closed | -$243K | – | 1445 |
|
|
2021
Q1 | $243K | Sell |
3,042
-10
| -0.3% | -$781 | 0.01% | 1282 |
|
|
2020
Q4 | $241K | Buy |
+3,052
| New | +$179K | 0.01% | 1221 |
|
|
2020
Q1 | – | Sell |
-3,152
| Closed | -$223K | – | 1395 |
|
|
2019
Q4 | $223K | Hold |
3,152
| – | – | 0.01% | 1288 |
|
|
2019
Q3 | $236K | Sell |
3,152
-180
| -5% | -$15.3K | 0.01% | 1182 |
|
|
2019
Q2 | $269K | Sell |
3,332
-279
| -8% | -$19.6K | 0.01% | 1150 |
|
|
2019
Q1 | $242K | Sell |
3,611
-60
| -2% | -$4.54K | 0.01% | 1230 |
|
|
2018
Q4 | $273K | Sell |
3,671
-1,790
| -33% | -$148K | 0.01% | 1134 |
|
|
2018
Q3 | $503K | Sell |
5,461
-170
| -3% | -$16.2K | 0.01% | 947 |
|
|
2018
Q2 | $554K | Buy |
5,631
+840
| +18% | +$94K | 0.01% | 879 |
|
|
2018
Q1 | $534K | Sell |
4,791
-4,032
| -46% | -$452K | 0.01% | 877 |
|
|
2017
Q4 | $908K | Sell |
8,823
-461
| -5% | -$45.9K | 0.02% | 678 |
|
|
2017
Q3 | $874K | Buy |
+9,284
| New | +$733K | 0.02% | 663 |
|
|
2016
Q3 | $874K | Buy |
+9,284
| New | +$674K | 0.02% | 663 |
|
Crossmark Global Holdings's CMD Position: Q2 2021 in Review
Crossmark Global Holdings sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 3,042 shares — an estimated $243K sold.
Crossmark Global Holdings first reported a position in CMD in Q3 2016 and held it in 13 quarters. The position peaked at $908K in Q4 2017. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Crossmark Global Holdings reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Crossmark Global Holdings sold 3,042 Cantel Medical Corporation shares in Q2 2021, an estimated $243K.
- Crossmark Global Holdings first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 13 quarters.
- Crossmark Global Holdings's Cantel Medical Corporation position peaked at $908K in Q4 2017.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Crossmark Global Holdings's 13F filing for Q2 2021, filed 21 Jul 2021.